Skip to main content

Rashed Dewan

Equibles does not estimate personal net worth.

About Rashed Dewan

Earlier roles on record: CFO at Profound Medical Corp. (PROF) until August 14, 2026. Profound Medical Corp. reported in an 8-K filed August 17, 2026 that Rashed Dewan resigned as Chief Financial Officer, effective August 14, 2026. Rashed Dewan has spoken on 16 earnings calls across 1 company, most recently for Profound Medical Corp. on March 5, 2026. The companies whose calls Rashed Dewan spoke on are classified in the Healthcare sector.

“On August 14, 2026, Rashed Dewan resigned from his position as Chief Financial Officer of the Company, effective the same day (the "Separation Date").”
Profound Medical Corp. Form 8-K, filed August 17, 2026 · Read the filing

Rashed Dewan on recent calls

“Good afternoon, everyone, and welcome to our Fourth Quarter and Full Year 2025 Conference Call. On behalf of the management team and everyone at Profound, I would like to thank you for your ongoing interest in our company.”
CFO, Profound Medical Corp. Q4 FY2025 Earnings Call ·
“On behalf of the management team and everyone at Profound, I would like to thank you for your ongoing interest in our company. For those of you who are shareholders, we appreciate your continued interest and support.”
CFO, Profound Medical Corp. Q3 FY2025 Earnings Call ·
“On behalf of the management team and everyone at Profound, I would like to thank you for your ongoing interest in our company. For those of you who are shareholders, we appreciate your continued interest and support.”
CFO, Profound Medical Corp. Q2 FY2025 Earnings Call ·
“On behalf of the management team and everyone at ProFound, I would like to thank you for your ongoing interest in our company. For those of you who are shareholders, we appreciate your continued interest and support.”
CFO, Profound Medical Corp. Q1 FY2025 Earnings Call ·
“On behalf of the management team and everyone at Profound, I would like to thank you for your ongoing interest in our company. For those of you who are shareholders, we appreciate your continued interest and support.”
CFO, Profound Medical Corp. Q4 FY2024 Earnings Call ·

Affiliation history

Company network

Recent activity

Show 5 earlier activities